Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LINES 2009 Neuroblastoma Protocol
NCT01728155Phase 3Completed
- Sponsor
- Health Research Institute Hospital La Fe
- Start
- Jan 2011
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of isotretinoin in neuroblastoma, ganglioneuroblastoma (GNB), sponsored by Health Research Institute Hospital La Fe. Started Jan 2011; status: completed.
02
Drugs
isotretinoin
03
Conditions
neuroblastomaganglioneuroblastoma (GNB)
Beyond the preview
Go deeper on NCT01728155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01728155.